In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific ...
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.
Scholars warn that replacing animal testing too quickly may threaten drug safety. As the FDA promotes AI and organoids, ...
A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...
A metal-free boron-chemistry approach facilitates the selective replacement of hydrogen atoms in complex molecules, ...
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy ...
FDA’s focus on playing a direct role in lowering drug prices may provide opportunities for some pharmaceutical companies to seek a regulatory advantage. But it also places enormous pressure on ...
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...
Explore how patient experience data shapes regulatory drug decisions, enhancing the patient-focused drug development initiative for better treatment outcomes. Patient experience data are critical to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results